We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRSH
3726
Marsh
MRSH
$87.5B
-14,341
Closed -$2.49M
MNOV icon
3727
MediciNova
MNOV
$65M
-110,200
Closed -$295K
MNSO icon
3728
MINISO
MNSO
$3.72B
-17,660
Closed -$182K
MO icon
3729
Altria Group
MO
$122B
-3,462
Closed -$164K
MOH icon
3730
Molina Healthcare
MOH
$10.4B
-300
Closed -$95K
MORN icon
3731
Morningstar
MORN
$6.94B
-417
Closed -$143K
MOS icon
3732
The Mosaic Company
MOS
$7.1B
-833,082
Closed -$32.7M
MPAA icon
3733
Motorcar Parts of America
MPAA
$264M
-7,436
Closed -$127K
MPC icon
3734
PUT
Marathon Petroleum
MPC
$91.2B
-2,100
Closed -$134K
MQ icon
3735
Marqeta
MQ
$1.85B
-2,416
Closed -$166K
MRC
3736
DELISTED
MRC Global
MRC
-1,246,666
Closed -$8.58M
MREO
3737
Mereo BioPharma
MREO
$48.2M
-98,288
Closed -$157K
MRKR icon
3738
Marker Therapeutics
MRKR
$20.3M
-12,348
Closed -$117K
MSCI icon
3739
MSCI
MSCI
$41.5B
-3,625
Closed -$2.22M
MSTR icon
3740
Strategy Inc
MSTR
$36B
-1,640
Closed -$89K
MTD icon
3741
Mettler-Toledo International
MTD
$27B
-2,441
Closed -$4.14M
MTDR icon
3742
Matador Resources
MTDR
$5.86B
-20,715
Closed -$765K
MTLS
3743
Materialise
MTLS
$373M
-132,750
Closed -$3.17M
MTUM icon
3744
iShares MSCI USA Momentum Factor ETF
MTUM
$25.2B
-31,401
Closed -$5.71M
BINI
3745
DELISTED
Bollinger Innovations
BINI
0
-$364K
MUSA icon
3746
Murphy USA
MUSA
$11.3B
-182,305
Closed -$36.3M
MVST icon
3747
Microvast
MVST
$267M
-149,850
Closed -$847K
MXCT icon
3748
MaxCyte
MXCT
$109M
-986,437
Closed -$10.1M
NAUT icon
3749
Nautilus Biotechnolgy
NAUT
$211M
-37,713
Closed -$195K
NBHC icon
3750
National Bank Holdings
NBHC
$1.89B
-6,052
Closed -$266K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.